ConductScience.org, home

Paper9704717

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Fisher B and 15 others. J Clin Oncol, 1998. Cited by 1,728 papers, by iCite.

Cite this record

ConductScience Library. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Papers, record 9704717. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9704717

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
PubMed
Journal
J Clin Oncol
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,728
iCite
Relative citation ratio, by iCite
43
iCite
Revised in PubMed
2024-06-27
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher BB
2Bryant JJ
3Wolmark NN
4Mamounas EE
5Brown AA
6Fisher ERE R
7Wickerham DLD L
8Begovic MM
9DeCillis AA
10Robidoux AA
11Margolese RGR G
12Cruz AB JrA B
13Hoehn JLJ L
14Lees AWA W
15Dimitrov NVN V
16Bear HDH D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
Combined Modality Therapy
Cyclophosphamide
Disease-Free Survival
Doxorubicin
Female
Humans
Middle Aged
Prognosis
Proportional Hazards Models
Survival Rate

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NCI-U10-CA-12027NCI NIH HHSUnited StatesPubMedPubMed
NCI-U10-CA-37377NCI NIH HHSUnited StatesPubMedPubMed
NCI-U10-CA-39086NCI NIH HHSUnited StatesPubMedPubMed
U10CA012027NIHNIH RePORTER
U10CA037377NIHNIH RePORTER
U10CA039086NIHNIH RePORTER

Download CSV of grants

Trials6

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00820690Neoadjuvant Chemotherapy in Locally Advanced Breast CancerBackgroundClinicalTrials.gov
NCT01309607Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerBackgroundClinicalTrials.gov
NCT01589367Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast CancerBackgroundClinicalTrials.gov
NCT02005887TRial on the Endocrine Activity of Neoadjuvant DegarelixBackgroundClinicalTrials.gov
NCT06130241Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?BackgroundClinicalTrials.gov
NCT07220135Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast CancerBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Reprinted in36989610Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.https://conductscience.org/library/papers/36989610

Source PubMed

Download CSV of comments and corrections

Cited by609

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,728 citations.

PMIDTitleJournalYearIn PapersSource
42957270Patient-reported Symptom Resolution After Neoadjuvant Versus Adjuvant Chemotherapy for Early Breast Cancer: A Prospective Observational Cohort Study.In Vivo2026https://conductscience.org/library/papers/42957270PubMed
42804883Performance of large language models in ambiguous treatment scenarios of early breast cancer.Breast2026https://conductscience.org/library/papers/42804883PubMed
42768249Equivalent survival in targeted axillary dissection compared to axillary lymph node dissection in patients with node positive breast cancer receiving neoadjuvant chemotherapy.Breast Cancer Res Treat2026https://conductscience.org/library/papers/42768249PubMed
42741650Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer.Oncol Lett2026https://conductscience.org/library/papers/42741650PubMed
42690897Value of shear wave elastography in evaluating response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.J Int Med Res2026https://conductscience.org/library/papers/42690897PubMed
42650907Multi-Parametric Ultrasound Radiomic Kinetics with Machine Learning Ensemble for Early Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.Diagnostics (Basel)2026https://conductscience.org/library/papers/42650907PubMed
42286385Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancer.Breast Cancer2026https://conductscience.org/library/papers/42286385PubMed
42194721Baseline and Early-Delta Quantitative Ultrasound Radiomics for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.J Clin Med2026https://conductscience.org/library/papers/42194721PubMed
42180128Breast cancer chemotherapy in transition: predictive markers, resistance mechanisms, and new treatment approaches.Front Oncol2026https://conductscience.org/library/papers/42180128PubMed
42120874Clinical significance of residual microcalcifications after neoadjuvant chemotherapy: MRI response and the subtypes.NPJ Breast Cancer2026https://conductscience.org/library/papers/42120874PubMed
42046781Vacuum-Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study).Int J Breast Cancer2026https://conductscience.org/library/papers/42046781PubMed
41873909Assessment of Surgical Approach and Overall Survival in Young Women With Breast Cancer.Eur J Breast Health2026https://conductscience.org/library/papers/41873909PubMed
41850052Impact of breast reconstruction and different surgical approaches after neoadjuvant therapy on the long-term survival of breast cancer patients.Transl Oncol2026https://conductscience.org/library/papers/41850052PubMed
41831424Histopathological evaluation of local effects of radioactive iodine seeds in axillary lymph nodes in clinically node-positive breast cancer treated with neoadjuvant systemic therapy.Breast2026https://conductscience.org/library/papers/41831424PubMed
41641261Case Report: Comparison different response after neoadjuvant chemotherapy of the breast with cell-in-cell-report of two cases.Front Med (Lausanne)2025https://conductscience.org/library/papers/41641261PubMed
41383511Patterns of response of breast cancer after neoadjuvant chemotherapy according to molecular subtype.Front Oncol2025https://conductscience.org/library/papers/41383511PubMed
41352211Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review.Breast2026https://conductscience.org/library/papers/41352211PubMed
41333222Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy.Front Oncol2025https://conductscience.org/library/papers/41333222PubMed
41274990Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.Sci Rep2025https://conductscience.org/library/papers/41274990PubMed
41217951Neoadjuvant vs. Adjuvant Chemotherapy for Luminal B Breast Cancer: A Systematic Review and Meta-Analysis - Where is the Evidence?Cancer Control2025https://conductscience.org/library/papers/41217951PubMed

See all 609 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9704717

GET https://conductscience.org/api/papers/v1/9704717/cited_by?page=2